| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
144,005 |
141,291 |
$14.03M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
159,674 |
156,701 |
$10.89M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
102,381 |
100,574 |
$10.13M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
37,341 |
36,868 |
$5.79M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21,434 |
21,026 |
$3.36M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
85,626 |
84,575 |
$2.32M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
4,016 |
3,973 |
$619K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,835 |
5,743 |
$376K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,410 |
4,375 |
$241K |
| 71046 |
Radiologic examination, chest; 2 views |
8,430 |
8,316 |
$160K |
| 90378 |
|
40 |
40 |
$131K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,778 |
4,697 |
$118K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,819 |
2,761 |
$117K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,261 |
960 |
$84K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
707 |
705 |
$73K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
632 |
628 |
$65K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
663 |
655 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
803 |
793 |
$45K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
333 |
323 |
$36K |
| 81001 |
|
6,594 |
6,425 |
$29K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,512 |
2,442 |
$27K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
5,534 |
5,453 |
$25K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
3,997 |
3,579 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
445 |
416 |
$17K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
9,365 |
9,243 |
$13K |
| 99000 |
|
5,139 |
4,897 |
$10K |
| 99460 |
|
104 |
104 |
$9K |
| 51701 |
|
162 |
157 |
$9K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
63 |
62 |
$8K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
79 |
79 |
$8K |
| 86140 |
|
779 |
758 |
$5K |
| J3490 |
Unclassified drugs |
1,980 |
1,930 |
$5K |
| 99215 |
Prolong outpt/office vis |
28 |
28 |
$4K |
| 92567 |
|
200 |
197 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
2,499 |
2,435 |
$4K |
| 74019 |
|
174 |
172 |
$4K |
| 94664 |
|
139 |
130 |
$2K |
| 80053 |
Comprehensive metabolic panel |
160 |
157 |
$2K |
| 99051 |
|
104 |
101 |
$2K |
| 96127 |
|
376 |
367 |
$2K |
| 73610 |
|
93 |
91 |
$2K |
| 74018 |
|
96 |
95 |
$2K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
2,871 |
2,621 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
19 |
15 |
$1K |
| 72081 |
|
44 |
44 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
52 |
52 |
$931.85 |
| 96160 |
|
197 |
195 |
$801.75 |
| 90686 |
|
797 |
781 |
$761.35 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
64 |
56 |
$744.14 |
| D1206 |
Topical application of fluoride varnish |
38 |
37 |
$730.21 |
| 70360 |
|
43 |
43 |
$679.66 |
| 92551 |
|
134 |
122 |
$584.07 |
| 73630 |
|
25 |
25 |
$494.60 |
| A6451 |
Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard |
340 |
332 |
$493.54 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
16 |
$478.71 |
| A4590 |
Special casting material (e.g., fiberglass) |
15 |
15 |
$449.40 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
201 |
170 |
$393.30 |
| 99173 |
|
155 |
142 |
$360.78 |
| 94010 |
|
15 |
15 |
$359.82 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
28 |
27 |
$330.67 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
239 |
219 |
$297.00 |
| 81003 |
|
85 |
85 |
$243.13 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
442 |
438 |
$224.58 |
| 85018 |
|
72 |
67 |
$215.12 |
| 73140 |
|
14 |
13 |
$214.50 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
17 |
12 |
$214.25 |
| 85652 |
|
56 |
55 |
$211.76 |
| 81002 |
|
51 |
49 |
$174.65 |
| 96161 |
|
39 |
39 |
$156.55 |
| 97802 |
|
1,242 |
1,238 |
$104.23 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
12 |
$38.93 |
| 36416 |
|
75 |
70 |
$8.40 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
40 |
40 |
$6.94 |
| S9451 |
Exercise classes, non-physician provider, per session |
1,125 |
1,125 |
$0.00 |
| 90688 |
|
62 |
62 |
$0.00 |
| 90651 |
|
66 |
66 |
$0.00 |
| 90620 |
|
15 |
15 |
$0.00 |
| 99070 |
|
12 |
12 |
$0.00 |
| 92558 |
|
14 |
12 |
$0.00 |
| 94760 |
|
16 |
15 |
$0.00 |
| 90723 |
|
13 |
13 |
$0.00 |
| 90670 |
|
45 |
43 |
$0.00 |
| 99072 |
|
564 |
527 |
$0.00 |
| 98960 |
|
13 |
13 |
$0.00 |
| 90672 |
|
94 |
94 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |
| 90734 |
|
43 |
43 |
$0.00 |
| 5250F |
|
14 |
14 |
$0.00 |